Klinisch orientierter Schwerpunkt
FB 04 - Universitätsmedizin / Johannes Gutenberg-Universität Mainz
Finn, R. S.; Qin, S-K.; Galle, P. R. et al.
Ramucirumab in patients with advanced hepatocellular carcinoma and elevated alpha fetoprotein following a non-sorafenib based systemic therapy: An expansion cohort of the phase III REACH-2 studyANNALS OF ONCOLOGY. Bd. 31. 2020 S. S702-S702
Harter, P.; Sehouli, J.; Meier, W. et al.
Randomized phase III study to evaluate the impact of secondary cytoreductive surgery in recurrent ovarian cancer - final analysis of AGO DESKTOP III/ENGOT-ov20GEBURTSHILFE UND FRAUENHEILKUNDE. Bd. 80. H. 10. 2020 S. E79-E79
Huettl, F.; Lang, H.; Paschold, M. et al.
Rating of camera navigation skills in colorectal surgeryINTERNATIONAL JOURNAL OF COLORECTAL DISEASE. Bd. 35. H. 6. 2020 S. 1111-1115
Zumla, Alimuddin; Wang, Fu-Sheng; Ippolito, Giuseppe et al.
Reducing mortality and morbidity in patients with severe COVID-19 disease by advancing ongoing trials of Mesenchymal Stromal (stem) Cell (MSC) therapy - Achieving global consensus and visibility for cellular host-directed therapiesINTERNATIONAL JOURNAL OF INFECTIOUS DISEASES. Bd. 96. 2020 S. 431-439
Moehler, Markus H.; Stein, Alexander; Trojan, Jorg et al.
Regorafenib with TAS-102 (REGOTAS) in metastatic colorectal cancer patients who progressed after at least two standard therapies: Efficacy and safety results of a multicenter phase I study (REMETY)JOURNAL OF CLINICAL ONCOLOGY. Bd. 38. H. 4. 2020
Moehler, M.; Stein, A.; Trojan, J. et al.
Regorafenib with TAS-102 in metastatic colorectal cancer patients who progressed after at least two standard therapies: Efficacy and safety results of a multicenter phase I study (REMETY)ANNALS OF ONCOLOGY. Bd. 31. 2020 S. S214-S214
Bartsch, Fabian; Hahn, Felix; Mueller, Lukas et al.
Relevance of suspicious lymph nodes in preoperative imaging for resectability, recurrence and survival of intrahepatic cholangiocarcinomaBMC SURGERY. Bd. 20. H. 1. 2020
Baaken, D.; Hammer, G. P.; Seidenbusch, M. C. et al.
Reply to 'Comment on: Baaken D, Hammer GP, Seidenbusch MC, Schneider K, Spix C, Blettner M, Pokora R and Lorenz E 2019 Second follow-up of a German cohort on childhood cancer after exposure to postnatal diagnostic x-ray J. Radiol. Prot. 39 1074-91'JOURNAL OF RADIOLOGICAL PROTECTION. Bd. 40. H. 3. 2020 S. 920-921
Buechner, Philipp; Hinderer, Marc; Unberath, Philipp et al.
Requirements Analysis and Specification for a Molecular Tumor Board Platform Based on cBioPortalDIAGNOSTICS. Bd. 10. H. 2. 2020
Fuerstenau, M.; Bahlo, J.; Fink, A. M. et al.
Residual abdominal lymphadenopathy after intensive frontline chemoimmunotherapy is associated with inferior outcome independently of minimal residual disease status in chronic lymphocytic leukemiaLEUKEMIA. Bd. 34. H. 3. 2020 S. 924-928